Longitudinal specialty/rare-disease patient treatment-journey panel

Name: Longitudinal specialty/rare-disease patient treatment-journey panel: consented and de-identified pharmacy, provider, hub and distribution data linked into unified patient journeys — benefit verification and access outcomes, prescription initiation and abandonment events, refill/continuation and time-on-therapy series, omnichannel outreach and intervention logs, and cross-brand performance benchmarks.
Creator: Claritas Rx

CLARITAS RXA5 · direct accessManage supplier listing

Longitudinal specialty/rare-disease patient treatment-journey panel: consented and de-identified pharmacy, provider, hub and distribution data linked into unified patient journeys — benefit verification and access outcomes, prescription initiation and abandonment events, refill/continuation and time-on-therapy series, omnichannel outreach and intervention logs, and cross-brand performance benchmarks.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Claritas Rx and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Pharmaceuticals
Instruments: equities
Categories: AlternativeFundamental
Regions: US
Sample tickers: REGNAMGNBIIBVRTXSRPTNBIXALNYIONS

Dataset card

Type: not stated
Format: Multimodal — longitudinal tabular claims/dispensing records joined with event-log style CRM interaction records (call, SMS, email, chat), delivered through a hosted analytics platform with report/extract export
Volume: Est. multi-million longitudinal patient journeys across specialty, rare and cell & gene therapies (inferred from ~140 employees and ~$15M revenue supporting a national hub/pharmacy aggregation footprint)
Users: N/A — B2B platform licensed to pharma/biotech brands, not a registered-user product; scale is measured in linked patient journeys rather than accounts
History: 15 years
Update frequency: not stated
Growth: Active — publishing current-period research (Everest Group white paper), running a demo funnel, and visibly celebrating a 15-year milestone with rebranded Ascend platform assets
Launched: ~2011 for the company (15-year anniversary logo on site); the integrated Ascend platform product layer is more recent, est. 2023-2025
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site

Claritas Rx has not added their own details yet. Not yet on file:

Dataset
Data dictionary
Coverage
Provenance
Rights & data handling